Allarity Therapeutics (ALLR) Institutional Ownership $0.94 -0.10 (-9.62%) Closing price 03/31/2025 04:00 PM EasternExtended Trading$1.00 +0.06 (+6.38%) As of 03/31/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Allarity Therapeutics (NASDAQ:ALLR)CurrentInstitutional OwnershipPercentage11.53%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$78.73KNumber ofInstitutional Sellers(last 12 months)0 Get ALLR Insider Trade Alerts Want to know when executives and insiders are buying or selling Allarity Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Remove Ads Allarity Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025Stonepine Capital Management LLC67,289$79K0.1%N/A1.518% 11/15/2023Sabby Management LLC359,400$268K0.2%N/A13.165% 11/15/2023Armistice Capital LLC261,000$195K0.0%N/A9.560% (Data available from 1/1/2016 forward)Remove Ads ALLR Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ALLR shares? During the previous two years, the following institutional investors and hedge funds held shares of Allarity Therapeutics shares: Sabby Management LLC ($268K), and Armistice Capital LLC ($195K), Stonepine Capital Management LLC ($79K).Learn more on ALLR's institutional investors. What percentage of Allarity Therapeutics stock is owned by institutional investors? 11.53% of Allarity Therapeutics stock is owned by institutional investors. Learn more on ALLR's institutional investor holdings. Which institutional investors have been buying Allarity Therapeutics stock? The following institutional investors have purchased Allarity Therapeutics stock in the last 24 months: Sabby Management LLC ($359.40K), Armistice Capital LLC ($261K), and Stonepine Capital Management LLC ($67.29K). How much institutional buying is happening at Allarity Therapeutics? Institutional investors have bought a total of 687,689 shares in the last 24 months. This purchase volume represents approximately $278.14M in transactions. Related Companies Elevation Oncology Major Shareholders NextCure Major Shareholders GlycoMimetics Major Shareholders BriaCell Therapeutics Major Shareholders Carisma Therapeutics Major Shareholders Sol-Gel Technologies Major Shareholders MEI Pharma Major Shareholders Imunon Major Shareholders Synlogic Major Shareholders Leap Therapeutics Major Shareholders This page (NASDAQ:ALLR) was last updated on 4/1/2025 by MarketBeat.com Staff From Our PartnersNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredNew “Trump” currency proposed in DCA former U.S. Presidential Advisor has come forward with a stern warning to investors: “Get out of tech, no...Paradigm Press | SponsoredLive Footage From Elon Musk’s “Area 51”What’s happening inside this nondescript building in South Memphis is so incredible… That Elon’s competitor...Brownstone Research | SponsoredTermination: 18F (read immediately)Have you ever heard of the government's 18F program? It helped manage digital services across the governmen...Altimetry | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | Sponsored“Massive Financial Reset Is Coming”The U.S. markets will see a massive reset, beginning days from now. But the "reset" isn't what you might ex...InvestorPlace | SponsoredGold Hits $3,000… Here’s How You Can Get More for Under $20With gold surging to record highs, currently trading above $3,000 an ounce, and central banks aggressively sto...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Allarity Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Allarity Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ALLR Stock Free ALLR Stock Alerts